Baltimore settled with opioid manufacturer Johnson & Johnson and its subsidiary Janssen Pharmaceuticals on the eve of its trial against that company and two distributors of opioids that the city accused of aggressively marketing the drugs and pumping them into pharmacies here.
The terms of the settlement were not outlined in a Sunday night court filing announcing the agreement.
Johnson & Johnson declined to comment on the settlement, while Baltimore City Solicitor Ebony Thompson and a spokesman for Democratic Mayor Brandon Scott did not respond immediately to questions.
Before the latest settlement, Baltimore had won $402.5 million from settlements with various opioid companies.
Baltimore’s remaining claims against opioid distributors McKesson and AmerisourceBergen appear slated to proceed to trial this week. Jury selection was scheduled to begin Monday and it could take several days for attorneys to find jurors who are able to preside over a trial slated to go on through November.
This article will be updated.